In Re Thomas F. Deuel, Yue-Sheng Li, Ned R. Siegel and Peter G. Milner Case Brief

Court of Appeals for the Federal Circuit1995Docket #552250
51 F.3d 1552 34 U.S.P.Q. 2d (BNA) 1210 1995 U.S. App. LEXIS 6200 1995 WL 131995

Complete case briefs with LSD+

Every LSD.Law brief pairs a full IRAC analysis with opinion summaries at three levels of depth, written by a team of Harvard Law and MIT graduates - a quick synopsis when you are pressed for time, the complete reasoning when you need to go deep.

Adaptive Case Views

Toggle between Flash, Standard, and Expanded. Get what you need, when you need it.

Exam-Ready IRAC Format

We deliver the precise structure professors look for in exam answers.

Complex Cases, Clarified

We break down dense legal reasoning into something digestible, helping you grasp core concepts.

Case Brief Summary & Legal Analysis

4 min read

tl;dr: The court reversed the PTO’s obviousness rejection of claims for specific DNA sequences, holding that knowledge of a partial protein sequence and general cloning methods does not render the specific DNA encoding that protein obvious due to genetic code redundancy.

Legal Significance: Established that a specific DNA sequence is not obvious merely because the encoded protein (or part of it) and general cloning methods are known, absent prior art suggesting the particular DNA structure.

In Re Thomas F. Deuel, Yue-Sheng Li, Ned R. Siegel and Peter G. Milner Law School Study Guide

Use this case brief structure for your own legal analysis. Focus on the IRAC methodology to excel in law school exams and cold calls.

Case Facts & Court Holding

Key Facts & Case Background

Deuel claimed isolated and purified DNA and cDNA molecules encoding heparin-binding growth factors (HBGFs). Claims 5 and 7 were for specific cDNA sequences for human and bovine HBGFs, respectively, while Claims 4 and 6 generically covered all DNA sequences encoding these proteins. The U.S. Patent and Trademark Office (PTO) rejected these claims as obvious under 35 U.S.C. § 103. The rejection combined prior art: Bohlen, which disclosed a partial N-terminal amino acid sequence of similar proteins (HBBMs), and Maniatis, which described a general method for gene cloning. The examiner and the Board of Patent Appeals and Interferences reasoned that Bohlen’s disclosure of the protein sequence would motivate one skilled in the art to isolate the corresponding gene using Maniatis’s general cloning methods, thereby rendering the claimed DNA/cDNA molecules obvious. Deuel had isolated the specific cDNAs after determining a partial amino acid sequence of the target protein and subsequently screening cDNA libraries.

Court Holding & Legal Precedent

Issue: Did the prior art disclosure of a partial protein amino acid sequence and a general method for gene cloning render specific cDNA molecules encoding that protein obvious under 35 U.S.C. § 103?

No. The court reversed the Board’s decision, holding that the claimed specific Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit ame

Read the full analysis

The complete holding, rule, and analysis for this case are available to LSD+ subscribers.

Start 14-Day Free Trial

IRAC Legal Analysis

Premium Feature Unlock

About IRAC analysis

IRAC (Issue, Rule, Analysis, Conclusion) is the structure professors expect in exam answers. Each LSD.Law brief states the issue, the governing rule with citations, the court's application of that rule, and the conclusion - the same reasoning pattern you will use on exams and in practice.

Legal Issue

Did the prior art disclosure of a partial protein amino acid sequence and a general method for gene cloning render specific cDNA molecules encoding that protein obvious under 35 U.S.C. § 103?

Conclusion

This case significantly clarified that knowledge of a protein's amino acid sequence Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excep

Legal Rule

For a chemical compound to be prima facie obvious, the prior art Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occ

Legal Analysis

The court reasoned that a prima facie case of obviousness for new Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo c

Flash-to-Full Case Opinions

Flash Summary

  • Knowledge of a protein’s partial amino acid sequence and a general
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Lorem ipsum dolor sit amet, cons

Read the full analysis

The complete holding, rule, and analysis for this case are available to LSD+ subscribers.

Start 14-Day Free Trial